IBDEI0GF ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7112,0)
 ;;=C7A.8^^58^467^3
 ;;^UTILITY(U,$J,358.3,7112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7112,1,3,0)
 ;;=3^Malig Neuroendocrine Tumors NEC
 ;;^UTILITY(U,$J,358.3,7112,1,4,0)
 ;;=4^C7A.8
 ;;^UTILITY(U,$J,358.3,7112,2)
 ;;=^5001380
 ;;^UTILITY(U,$J,358.3,7113,0)
 ;;=C82.90^^58^467^2
 ;;^UTILITY(U,$J,358.3,7113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7113,1,3,0)
 ;;=3^Follicular Lymphoma
 ;;^UTILITY(U,$J,358.3,7113,1,4,0)
 ;;=4^C82.90
 ;;^UTILITY(U,$J,358.3,7113,2)
 ;;=^5001541
 ;;^UTILITY(U,$J,358.3,7114,0)
 ;;=C90.00^^58^467^4
 ;;^UTILITY(U,$J,358.3,7114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7114,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,7114,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,7114,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,7115,0)
 ;;=D09.0^^58^467^1
 ;;^UTILITY(U,$J,358.3,7115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7115,1,3,0)
 ;;=3^Carcinoma in Situ of Bladder
 ;;^UTILITY(U,$J,358.3,7115,1,4,0)
 ;;=4^D09.0
 ;;^UTILITY(U,$J,358.3,7115,2)
 ;;=^267742
 ;;^UTILITY(U,$J,358.3,7116,0)
 ;;=J30.9^^58^468^1
 ;;^UTILITY(U,$J,358.3,7116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7116,1,3,0)
 ;;=3^Allergic Rhinitis,Unspec
 ;;^UTILITY(U,$J,358.3,7116,1,4,0)
 ;;=4^J30.9
 ;;^UTILITY(U,$J,358.3,7116,2)
 ;;=^5008205
 ;;^UTILITY(U,$J,358.3,7117,0)
 ;;=J31.0^^58^468^3
 ;;^UTILITY(U,$J,358.3,7117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7117,1,3,0)
 ;;=3^Chronic Rhinitis
 ;;^UTILITY(U,$J,358.3,7117,1,4,0)
 ;;=4^J31.0
 ;;^UTILITY(U,$J,358.3,7117,2)
 ;;=^24434
 ;;^UTILITY(U,$J,358.3,7118,0)
 ;;=J44.9^^58^468^2
 ;;^UTILITY(U,$J,358.3,7118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7118,1,3,0)
 ;;=3^Chronic Obstructive Pulmonary Disease,Unspec
 ;;^UTILITY(U,$J,358.3,7118,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,7118,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,7119,0)
 ;;=J45.40^^58^468^4
 ;;^UTILITY(U,$J,358.3,7119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7119,1,3,0)
 ;;=3^Moderate Persistent Asthma,Uncomplicated
 ;;^UTILITY(U,$J,358.3,7119,1,4,0)
 ;;=4^J45.40
 ;;^UTILITY(U,$J,358.3,7119,2)
 ;;=^5008248
 ;;^UTILITY(U,$J,358.3,7120,0)
 ;;=R07.0^^58^469^14
 ;;^UTILITY(U,$J,358.3,7120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7120,1,3,0)
 ;;=3^Pain in Throat
 ;;^UTILITY(U,$J,358.3,7120,1,4,0)
 ;;=4^R07.0
 ;;^UTILITY(U,$J,358.3,7120,2)
 ;;=^5019195
 ;;^UTILITY(U,$J,358.3,7121,0)
 ;;=R07.2^^58^469^20
 ;;^UTILITY(U,$J,358.3,7121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7121,1,3,0)
 ;;=3^Precordial Pain
 ;;^UTILITY(U,$J,358.3,7121,1,4,0)
 ;;=4^R07.2
 ;;^UTILITY(U,$J,358.3,7121,2)
 ;;=^5019197
 ;;^UTILITY(U,$J,358.3,7122,0)
 ;;=R07.81^^58^469^19
 ;;^UTILITY(U,$J,358.3,7122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7122,1,3,0)
 ;;=3^Pleurodynia
 ;;^UTILITY(U,$J,358.3,7122,1,4,0)
 ;;=4^R07.81
 ;;^UTILITY(U,$J,358.3,7122,2)
 ;;=^5019198
 ;;^UTILITY(U,$J,358.3,7123,0)
 ;;=R07.9^^58^469^3
 ;;^UTILITY(U,$J,358.3,7123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7123,1,3,0)
 ;;=3^Chest Pain,Unspec
 ;;^UTILITY(U,$J,358.3,7123,1,4,0)
 ;;=4^R07.9
 ;;^UTILITY(U,$J,358.3,7123,2)
 ;;=^5019201
 ;;^UTILITY(U,$J,358.3,7124,0)
 ;;=R10.2^^58^469^17
 ;;^UTILITY(U,$J,358.3,7124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7124,1,3,0)
 ;;=3^Pelvic and Perineal Pain
 ;;^UTILITY(U,$J,358.3,7124,1,4,0)
 ;;=4^R10.2
 ;;^UTILITY(U,$J,358.3,7124,2)
 ;;=^5019209
